Related Experiment Video
Updated: Mar 8, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research
Primavera A Spagnolo1, David Goldman1,2
1Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Neuromodulation techniques offer promising new ways to target brain circuits involved in addiction. Further research is needed to confirm the long-term safety and effectiveness of these innovative treatments for addictive disorders.
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Background:
- Addictive disorders represent a significant global health challenge with limited treatment efficacy.
- Addiction phenotypes are linked to neural circuit dysregulation, supported by preclinical and neuroimaging data.
Purpose of the Study:
- To review the current literature on neuromodulation interventions for addictive disorders.
- To highlight advancements, limitations, and future research directions in this field.
Main Methods:
- Review of existing literature on neuromodulation in addictive disorders.
- Inclusion of both invasive (deep brain stimulation) and non-invasive (repetitive transcranial magnetic stimulation, transcranial direct current stimulation) techniques.
Main Results:
- Neuromodulation interventions show potential for probing and remodeling impaired neural circuits in addiction.
- The current body of literature is limited, and long-term safety and efficacy require further investigation.
Conclusions:
- Neuromodulation presents a promising therapeutic avenue for addictive disorders.
- Continued research is essential to validate the safety and efficacy of these interventions for clinical application.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Neurochemical Transmission: Sites of Drug Action
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

